Family Office Of America (FOFA) Cash from Financing Activities (2024 - 2025)
Family Office Of America recorded quarterly Cash from Financing Activities of $50000.0 in Q4 2025, down 80.77% quarter-over-quarter from $260000.0 in Q3 2025.
Family Office Of America's Cash from Financing Activities history runs 2 years deep, the most recent figure standing at $50000.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities changed N/A year-over-year to $50000.0; the TTM figure through Dec 2025 stood at $965000.0 (up 859.96% YoY), while the FY2025 annual figure was $965000.0, up 859.96% from the prior year.
- Cash from Financing Activities came in at $50000.0 for Q4 2025 at Family Office Of America, down from $260000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $575000.0 in Q1 2025 to a low of $525.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Family Office Of America | - | - | 783,126.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Mar 31, 2025 | 575,000.00 |
| Mar 31, 2025 | 575,000.00 |
| Sep 30, 2024 | 525.00 |
| Sep 30, 2024 | 525.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |